{"id":"W2005204505","doi":"10.1177/1078155214533367","title":"Tolerability of Velcade (Bortezomib) subcutaneous administration using a maximum volume of 3 mL per injection site","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bortezomib; Tolerability; Dosing; Subcutaneous injection; Anesthesia; Route of administration; Multiple myeloma; Adverse effect; Pharmacology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006825953,0.0002075205,0.0006107501,0.0001168491,0.0001811528,0.0003778637,0.0001331004,0.0001942578,0.002529245],"category_scores_gemma":[0.001738506,0.0001094689,0.0004259297,0.0002224153,0.0001582901,0.0002808821,0.0001220435,0.0006522602,0.0004143898],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002166812,"about_ca_system_score_gemma":0.00021244,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006420898,"about_ca_topic_score_gemma":0.0005796957,"domain_scores_codex":[0.9996363,0.0001119332,0.00003729437,0.00004202767,0.0001322787,0.00004014276],"domain_scores_gemma":[0.9988897,0.0004302835,0.0003059611,0.00007669291,0.0001765961,0.0001207824],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.06430446,0.01718967,0.1417105,0.001908511,0.001081931,0.002409358,0.001706198,0.004847711,0.2812724,0.0004051049,0.004773492,0.4783906],"study_design_scores_gemma":[0.002735051,0.276772,0.6372052,0.0001128466,0.0008415123,0.005751954,0.0005162304,0.002859123,0.05812707,0.0002262566,0.01477685,0.00007590769],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918616,0.002472806,0.001277162,0.0001202014,0.00003250152,0.0002197014,0.0004421158,0.00005712481,0.003516771],"genre_scores_gemma":[0.9976161,0.0004555032,0.0003592222,0.0001245965,0.00003588411,0.00006821939,0.0002051855,0.00001442868,0.001120906],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002529245,"threshold_uncertainty_score":0.008461118,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0622537412032568,"score_gpt":0.4347714572492852,"score_spread":0.3725177160460283,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}